Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance

Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Clin Microbiol
Hauptverfasser:	Wilson, K. E., Cassiday, P. K., Popovic, T., Sanden, G. N.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2002
Schlagworte:	Bacteriology
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120648/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12149356/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.8.2942-2944.2002
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!